BNP PARIBAS ARBITRAGE, SA
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1166588
NEW YORK, NY
Position in ARWR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$45,534,990
+$4,742,433 QoQ
Shares Held
558,643
-14.1% QoQ
Ownership
0.395%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#39
of 497 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BNP PARIBAS ARBITRAGE, SA holds $3,275,701,265 across 414 Biotechnology names. ARWR ranks #21 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
4,377,120 | $306,529,713 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
399,847 | $249,320,598 | |
| 3 | ARGX |
Argenx SE
|
157,958 | $146,548,693 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
262,258 | $130,271,416 | |
| 5 | BNTX |
BioNTech SE
|
1,319,517 | $122,781,056 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
552,710 | $103,511,528 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
1,079,015 | $102,689,857 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,155,442 | $86,057,320 |
All Filings in ARWR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,534,990 | 558,643 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $40,792,557 | 650,599 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $2,682,023 | 40,398 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,757,748 | 50,964 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $534,419 | 33,824 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,055,165 | 82,823 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,654,945 | 88,029 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,068,991 | 55,188 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,024,109 | 39,404 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,320,202 | 116,091 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $7,454,313 | 243,605 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $5,763,104 | 214,481 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,919,818 | 109,922 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $3,984,752 | 156,880 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $4,001,771 | 98,663 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $4,270,324 | 129,208 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $1,666,700 | 47,336 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,465,569 | 53,611 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $3,173,648 | 47,868 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $1,795,237 | 28,756 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $1,624,265 | 19,612 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $1,866,493 | 28,148 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $1,653,838 | 21,554 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $645,555 | 14,992 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $587,254 | 13,597 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $778,918 | 27,074 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||